Sabina A Guler,Yet H Khor,Anne E Holland et al.
Sabina A Guler et al.
Purpose of review: Oxygen therapy is a key component of interstitial lung disease (ILD) management. This review summarizes the current evidence and explores how to balance its benefits and burdens in people with ILD. ...
Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis [0.03%]
系统性硬化症相关肺动脉高压的临床前和临床研究进展
Anna Birnhuber,Katarina Zeder,Grazyna Kwapiszewska
Anna Birnhuber
Purpose of review: Systemic sclerosis (SSc) is a chronic, severe autoimmune disease characterized by progressive fibrosis of the skin and internal organs. Pulmonary (arterial) hypertension (P(A)H) is a common complication...
Carli J Lehr,Stephen C Juvet
Carli J Lehr
Association between upper airway obstruction and pulmonary hypertension in children with Down syndrome [0.03%]
唐氏综合征儿童上呼吸道梗阻与肺动脉高压的关系分析
Kevin Guy,Amal Isaiah
Kevin Guy
Purpose of review: Down syndrome (DS) is the most common nonlethal chromosomal aneuploidy, affecting 1 in 700 live births. Pulmonary hypertension (PH) occurs in approximately 25% of children with DS and contributes to a 1...
Molecular mechanisms of environmental risk factors for interstitial lung disease [0.03%]
间质性肺疾病的环境危险因素的分子机制
Gillian C Goobie
Gillian C Goobie
Purpose of review: Interstitial lung disease (ILD) comprises a diverse group of conditions characterized by lung inflammation and fibrosis. Cumulative lifetime exposures (i.e. the exposome) contribute to ILD onset and pro...
Leona Dowman,Emma Marshall,Yet H Khor
Leona Dowman
Purpose of review: This review synthesizes the role of functional testing in the care of interstitial lung disease (ILD), evaluating the clinical utility of current approaches and discussing innovative strategies that may...
Recent advances in the clinical management of end-stage pediatric pulmonary hypertension [0.03%]
儿童期终末期肺动脉高压的临床管理最新进展
Oscar van der Have,Rachel K Hopper,Rebecca J Kameny et al.
Oscar van der Have et al.
Purpose of review: This review aims to give an overview of recent advances in the clinical management of children
Precision immunosuppression in adult lung transplantation: are we there yet? [0.03%]
成人肺移植的精准免疫抑制：我们已经做到了吗？
Peter Jaksch,Alberto Benazzo,Gabriella Murakoezy
Peter Jaksch
Purpose of review: Long-term outcomes after adult lung transplantation remain limited by rejection, infection, and toxicity related to immunosuppressive therapy. Conventional protocol-based immunosuppression fails to acco...
Frank R Leuzzi,Emily S Clausen,Daniel F Dilling
Frank R Leuzzi
Purpose of review: Lung transplant remains the ultimate life-saving therapy for people with progressive end-stage lung disease. It is important to highlight the evolution of the field in the United States, as its developm...
Paula Appenzeller,Daniel Jeffery,Mark Toshner
Paula Appenzeller
Purpose of review: In pulmonary arterial hypertension (PAH), assessment of exercise provides important prognostic information. Recently, digital alternatives to traditional outcome measures, including digital versions of ...